In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

BridgeBio goes public netting $372.7mm

Executive Summary

BridgeBio Pharma Inc. netted $372.7mm in its oversubscribed initial public offering of 23.6mm common shares (including full exercise of the overallotment) at $17 each on the Nasdaq. The company had planned to sell 15mm shares between $14 and $16.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
    • Gene Therapy, Cell Therapy
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies